Basel Olten Pharm Spółka Akcyjna w Upadłości (KRS 0000607178, NIP 7010561531) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. BASEL OLTEN PHARM SPÓŁKA AKCYJNA W UPADŁOŚCI operates in: Wholesale of perfume and cosmetics (PKD 46.45.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since March 23, 2016. BASEL OLTEN PHARM SPÓŁKA AKCYJNA W UPADŁOŚCI's most recently reported net revenue was 0 PLN for 2024.
Negative equity
Negative equity in 6 of 7 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Basel Olten Pharm
Identity
- Name
- Basel Olten Pharm Spółka Akcyjna w Upadłości
- Legal form
- SPÓŁKA AKCYJNA
- Founded
- March 23, 2016
- Registry status as of
- March 12, 2026
- Latest entry
- March 12, 2026
- Founding act
- 18.02.2016 R., ZASTĘPCA NOTARIALNY MAGDALENA ZABIELSKA, ZASTĘPCA NOTARIUSZA LESZKA ZABIELSKIEGO, KANCELARIA NOTARIALNA L…
Articles of association history (5)
- February 18, 2016: 18.02.2016 R., ZASTĘPCA NOTARIALNY MAGDALENA ZABIELSKA, ZASTĘPCA NOTARIUSZA LESZKA ZABIELSKIEGO, KANCELARIA NOTARIALNA LESZEK ZABIELSKI, NOTARIUSZE - SPÓŁKA PARTNERSKA W WARSZAWIE, UL. GÓRSKIEGO 6 LOK. 2, REP. A NR 896/2016.
- June 22, 2016: STATUT SPÓŁKI ZMIENIONY W DN. 22.06.2016 R. W DRODZE AKTU NOTARIALNEGO SPORZĄDZONEGO ZA REP. A NR 4481/2016 PRZEZ JOANNĘ ŚLIZAK, NOTARIUSZ W WARSZAWIE. UCHYLONO W CAŁOŚCI DOTYCHCZASOWE BRZMIENIE STATUTU I PRZYJĘTO W CAŁOŚCI NOWE JEGO BRZMIENIE.
- September 8, 2016: AKT NOTARIALNY SPORZĄDZONY DN. 08.09.2016R., REP. A NR 6621/2016 PRZEZ NOTARIUSZA JOANNĘ ŚLIZAK PROWADZĄCĄ KANCELARIĘ NOTARIALNĄ W WARSZAWIE, UL. SIENNA 72 LOK.5, 00-833 WARSZAWA UCHYLONO PKT 5 I PRZYJĘTO JEGO NOWE BRZMIENIE
- December 9, 2016: 09.12.2016R., REP. A NR 10050/2016, NOTARIUSZ JOANNA ŚLIZAK, KANCELARIA NOTARIALNA UL. SIENNA 72 LOK. 5 W WARSZAWIE, ZMIANA: PKT 8.1;9.1;9.15.3;11-14, DODANO: PKT. 9.15.4.
- May 5, 2017: 05.05.2017R., REP. A NR 5537/2017, NOTARIUSZ JOANNA ŚLIZAK, KANCELARIA NOTARIALNA W WARSZAWIE, ZMIANA: PKT 8.1, PKT 8.7, PKT 9.8 STATUTU SPÓŁKI
Activities
Main activity
46.45.ZWholesale of perfume and cosmetics
Other activities
Address and contact
- Address
- UL. STANISŁAWA MONIUSZKI, 1A, 00-014, WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.2298, 21.0117approx.
Risk and payment profile - Basel Olten Pharm
Credibility rating
5.2 / 100
Very poor credibility
Insolvency risk
Very high
Significant formal threat
Closure risk
49
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
Spółka wykazuje sygnały niestabilności organizacyjnej: częste zmiany w zarządzie. Może to wskazywać na podwyższone ryzyko współpracy.
Shareholder changes
0
0/10 yrs
Board changes
7
7/10 yrs
PKD changes
1
1/10 yrs
Name changes
2
2/10 yrs
Data from 10 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (5/100)
Trend: stable (+1.3 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Basel Olten Pharm
Founded
March 23, 2016
10 years in operation
Legal form
SPÓŁKA AKCYJNA
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
46.45.Z
Wholesale of perfume and cosmetics
Share capital
612.7 K PLN
Shareholders
N/A
Board
N/A
Sup. board: 2
Filed years
7 years
2018–2024 · profitable: 0/7
Registry entries
36
latest: March 12, 2026
Risk signals
Revenue
0 PLN
2024
Net profit
-15.7 M PLN
2024
Assets
459.8 K PLN
2024
Equity
-82.0 M PLN
2024
EBITDA
N/A
2024
no depreciation data
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Basel Olten Pharm.
No ratings
Related articles
Explainer
Eurocash in 2026: Polish FMCG-wholesale leader and Delikatesy Centrum network, an mWIG40 issuer near Poznań, controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral, listed on the WSE since 2005, the company is an mWIG40 constituent. A six-member management board, a five-member supervisory board, chaired by the founder himself.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
